BSE Live
Dec 11, 16:01Prev. Close
1786.25
Open Price
1771.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 11, 15:57Prev. Close
1785.50
Open Price
1778.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1807.20 (160)
| Balance Sheet of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | |
| Total Share Capital | 239.93 | 239.93 | 239.93 | 239.93 | 240.66 | |
| Reserves and Surplus | 24,156.29 | 22,603.68 | 22,082.68 | 20,772.54 | 21,242.43 | |
| Total Reserves and Surplus | 24,156.29 | 22,603.68 | 22,082.68 | 20,772.54 | 21,242.43 | |
| Total Shareholders Funds | 24,396.22 | 22,843.61 | 22,322.61 | 21,012.47 | 21,483.09 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 1,256.69 | 1,422.50 | 1,564.69 | 760.64 | 1,929.27 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 161.72 | 19.12 | 0.91 | 0.68 | 13.57 | |
| Long Term Provisions | 1,391.96 | 157.07 | 345.18 | 1,132.83 | 1,924.55 | |
| Total Non-Current Liabilities | 2,810.37 | 1,598.69 | 1,910.78 | 1,894.15 | 3,867.39 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 4,488.27 | 4,428.05 | 5,213.81 | 4,054.04 | 3,733.72 | |
| Trade Payables | 2,129.27 | 2,154.92 | 2,565.97 | 2,072.60 | 1,772.44 | |
| Other Current Liabilities | 3,488.26 | 4,145.13 | 2,125.89 | 2,988.58 | 1,906.83 | |
| Short Term Provisions | 1,097.94 | 2,543.73 | 2,652.75 | 1,847.43 | 1,425.79 | |
| Total Current Liabilities | 11,203.74 | 13,271.83 | 12,558.42 | 10,962.65 | 8,838.78 | |
| Total Capital And Liabilities | 38,410.33 | 37,714.13 | 36,791.81 | 33,869.27 | 34,189.93 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 4,910.31 | 4,709.21 | 4,400.52 | 3,869.35 | 3,512.90 | |
| Intangible Assets | 318.43 | 269.21 | 244.05 | 169.28 | 55.27 | |
| Capital Work-In-Progress | 384.35 | 456.25 | 830.39 | 1,055.11 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 5,825.35 | 5,620.96 | 5,632.41 | 5,139.13 | 4,335.90 | |
| Non-Current Investments | 16,966.65 | 17,656.16 | 18,310.50 | 19,293.29 | 22,283.11 | |
| Deferred Tax Assets [Net] | 1,139.71 | 751.70 | 751.70 | 749.06 | 0.00 | |
| Long Term Loans And Advances | 0.74 | 1.00 | 3.42 | 4.87 | 2,165.47 | |
| Other Non-Current Assets | 2,536.76 | 2,514.54 | 2,518.57 | 2,294.73 | 61.75 | |
| Total Non-Current Assets | 26,469.21 | 26,544.36 | 27,216.60 | 27,481.08 | 28,846.23 | |
| CURRENT ASSETS | ||||||
| Current Investments | 395.07 | 247.95 | 44.76 | 40.01 | 82.49 | |
| Inventories | 2,633.67 | 2,792.62 | 2,135.64 | 2,308.28 | 2,132.16 | |
| Trade Receivables | 6,168.13 | 5,031.47 | 5,271.44 | 2,714.70 | 2,016.81 | |
| Cash And Cash Equivalents | 654.78 | 340.77 | 155.27 | 170.28 | 169.39 | |
| Short Term Loans And Advances | 448.59 | 294.73 | 52.05 | 13.85 | 745.03 | |
| OtherCurrentAssets | 1,640.88 | 2,462.23 | 1,916.05 | 1,141.07 | 197.82 | |
| Total Current Assets | 11,941.12 | 11,169.77 | 9,575.21 | 6,388.19 | 5,343.70 | |
| Total Assets | 38,410.33 | 37,714.13 | 36,791.81 | 33,869.27 | 34,189.93 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 3,863.62 | 5,549.82 | 1,186.57 | 5,829.14 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 588.46 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 59.22 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 59.22 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 201.22 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 2,796.39 | 3,861.02 | 3,014.34 | 2,448.41 | 1,270.04 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 7,421.87 | 6,602.54 | 4,081.64 | 4,411.81 | 3,957.17 | |
| Other Earnings | -- | -- | -- | -- | 259.93 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 183.81 | 183.81 | 183.81 | 183.81 | 184.37 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 8.16 | 139.67 | 190.14 | 66.52 | 54.19 | |
| Non-Current Investments Unquoted Book Value | 0.38 | 17,590.77 | 18,685.98 | 134.21 | 22,871.37 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | 11.23 | |
| Current Investments Unquoted Book Value | 392.37 | 245.26 | 42.07 | 40.01 | 73.56 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend